Moderna To Develop mRNA Vaccines in China
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.
The US and China may be taking jabs at one another over trade and other stuff, but that isn't stopping Beijing from inviting an American company to produce a new jab for the nation of 1.4 billion.
Moderna announced Wednesday it's struck a deal with Chinese officials to let it develop messenger RNA (mRNA) drugs in the country. It's a win that could pave the way for more Western vaccine producers looking to break into China.
Source Fool.com
Moderna Inc. Stock
€112.88
0.300%
With 17 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 129 € shows a slightly positive potential of 14.28% compared to the current price of 112.88 € for Moderna Inc..
